FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. Stock

Certificat

DE000MG318Z2

Market Closed - Börse Stuttgart 03:27:47 2024-05-23 pm EDT
10.41 EUR +8.89% Intraday chart for FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO.
Current month-4.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 10.41 +8.89%
24-05-22 9.56 +3.91%
24-05-21 9.2 -0.97%
24-05-20 9.29 -1.28%
24-05-17 9.41 +0.32%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 03:27 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MG318Z
ISINDE000MG318Z2
Date issued 2024-04-25
Strike 293.1 $
Maturity Unlimited
Parity 5.6 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 10.63
Lowest since issue 8.43
Spread 0.06
Spread %0.57%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
230.4 USD
Average target price
279 USD
Spread / Average Target
+21.12%
Consensus